Income Statement Verici Dx plc

Equities

VRCI

GB00BM8HZD43

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. Other stock markets 16:35:24 10/02/2026 GMT			5-day change	1st Jan Change
0.6900 ^GBX	-4.83%		-4.83%	-4.83%

02-05	EARNINGS AND TRADING: React sales increase; Arcontech profit declines	AN
02-05	Verici Dx's Tutivia Added as In-network Test Under BCBS Deal	MT

d56a1b682fa7357e7a776.lJwDRGqAB3sPfs-xHVFl4picV89i500UnbpR6zZSEYY.pq5ZPTXyZjVDDKDQRSMi1t7UL78ulx4k8e1pkXchKMLS2koDLPg0CkEhig

Published financial data: VERICI DX PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	-	-	-	1.01M	3.34M
Total Revenues	-	-	-	1.01M	3.34M
Gross Profit	-	-	-	1.01M	3.34M
Selling General & Admin Expenses, Total	2.39M	7.15M	10.5M	8.6M	8.71M
Depreciation & Amortization - (IS)	-	438K	640K	829K	701K
Other Operating Expenses, Total	2.39M	7.59M	11.14M	9.43M	9.41M
Operating Income	-2.39M	-7.59M	-11.14M	-8.41M	-6.07M
Interest Expense, Total	-105K	-	-5K	-29K	-22K
Interest And Investment Income	-	-	53K	162K	254K
Net Interest Expenses	-105K	-	48K	133K	232K
EBT, Excl. Unusual Items	-2.5M	-7.59M	-11.09M	-8.28M	-5.84M
Other Unusual Items	-4.61M	-741K	-318K	-453K	-35K
EBT, Incl. Unusual Items	-7.1M	-8.33M	-11.41M	-8.73M	-5.87M
Earnings From Continuing Operations	-7.1M	-8.33M	-11.41M	-8.73M	-5.87M
Net Income to Company	-7.1M	-8.33M	-11.41M	-8.73M	-5.87M
Net Income - (IS)	-7.1M	-8.33M	-11.41M	-8.73M	-5.87M
Net Income to Common Incl Extra Items	-7.1M	-8.33M	-11.41M	-8.73M	-5.87M
Net Income to Common Excl. Extra Items	-7.1M	-8.33M	-11.41M	-8.73M	-5.87M
Per Share Items
Net EPS - Basic	-0.08	-0.06	-0.07	-0.05	-0.03
Basic EPS - Continuing Operations	-0.08	-0.06	-0.07	-0.05	-0.03
Basic Weighted Average Shares Outstanding	86.73M	142M	165M	170M	233M
Net EPS - Diluted	-0.08	-0.06	-0.07	-0.05	-0.03
Diluted EPS - Continuing Operations	-0.08	-0.06	-0.07	-0.05	-0.03
Diluted Weighted Average Shares Outstanding	86.73M	142M	165M	170M	233M
Normalized Basic EPS	-0.02	-0.03	-0.04	-0.03	-0.02
Normalized Diluted EPS	-0.02	-0.03	-0.04	-0.03	-0.02
Supplemental Items
EBITDA	-2.1M	-7.15M	-10.5M	-7.58M	-5.37M
EBITA	-2.29M	-7.45M	-10.99M	-8.26M	-5.89M
EBIT	-2.39M	-7.59M	-11.14M	-8.41M	-6.07M
Normalized Net Income	-1.56M	-4.74M	-6.93M	-5.18M	-3.65M
Interest on Long-Term Debt	-	-	5K	29K	22K
Supplemental Operating Expense Items
General and Administrative Expenses	2.39M	7.15M	10.5M	8.6M	8.71M
Research And Development Expense From Footnotes	-	-	4.83M	2.43M	1.9M
Stock-Based Comp., G&A Exp. (Total)	4.19M	741K	318K	453K	35K
Total Stock-Based Compensation	4.19M	741K	318K	453K	35K

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	17.75M	10.34M	9.8M	2.64M	4.06M
Total Cash And Short Term Investments	17.75M	10.34M	9.8M	2.64M	4.06M
Accounts Receivable, Total	-	-	-	1.01M	-
Other Receivables	121K	250K	177K	87K	50K
Total Receivables	121K	250K	177K	1.1M	50K
Prepaid Expenses	203K	406K	343K	244K	454K
Total Current Assets	18.07M	11M	10.32M	3.99M	4.56M
Gross Property Plant And Equipment	594K	1.21M	2.89M	2.94M	2.95M
Accumulated Depreciation	-130K	-420K	-880K	-1.58M	-2.09M
Net Property Plant And Equipment	464K	786K	2.01M	1.36M	858K
Other Intangibles, Total	1.77M	2.01M	1.97M	2.09M	2.07M
Total Assets	20.31M	13.79M	14.3M	7.44M	7.49M
Liabilities
Accounts Payable, Total	394K	160K	960K	475K	658K
Accrued Expenses, Total	211K	1.64M	1.14M	1.32M	1.16M
Short-term Borrowings	73.55K	-	-	-	-
Current Portion of Leases	-	-	156K	163K	182K
Current Income Taxes Payable	3.06K	-	-	-	-
Unearned Revenue Current, Total	-	-	-	1.5M	-
Other Current Liabilities	-	-	-	48K	43K
Total Current Liabilities	682K	1.8M	2.25M	3.51M	2.04M
Long-Term Leases	-	-	544K	377K	189K
Total Liabilities	682K	1.8M	2.8M	3.88M	2.23M
Common Stock, Total	182K	182K	219K	219K	310K
Additional Paid In Capital	20.35M	20.35M	32.95M	32.95M	40.37M
Retained Earnings	-4.74M	-13.06M	-24.47M	-33.21M	-39.08M
Comprehensive Income and Other	3.82M	4.51M	2.82M	3.6M	3.67M
Total Common Equity	19.62M	11.98M	11.51M	3.56M	5.26M
Total Equity	19.62M	11.98M	11.51M	3.56M	5.26M
Total Liabilities And Equity	20.31M	13.79M	14.3M	7.44M	7.49M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	142M	170M	170M	243M	243M
ECS Total Common Shares Outstanding	142M	142M	170M	170M	243M
Book Value / Share	0.14	0.08	0.07	0.02	0.02
Tangible Book Value	17.86M	9.98M	9.54M	1.47M	3.2M
Tangible Book Value Per Share	0.13	0.07	0.06	0.01	0.01
Total Debt	73.55K	0	700K	540K	371K
Net Debt	-17.68M	-10.34M	-9.1M	-2.1M	-3.69M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	594K	1.21M	1.6M	1.65M	1.66M
Full Time Employees	8	10	15	14	18

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	-7.1M	-8.33M	-11.41M	-8.73M	-5.87M
Depreciation & Amortization - CF	185K	295K	497K	673K	522K
Amortization of Goodwill and Intangible Assets - (CF)	103K	143K	143K	156K	179K
Depreciation & Amortization, Total	288K	438K	640K	829K	701K
Stock-Based Compensation (CF)	4.19M	741K	318K	453K	35K
Other Operating Activities, Total	0	0	-48K	-133K	-232K
Change In Accounts Receivable	-485K	-331K	136K	-824K	840K
Change In Accounts Payable	1.02M	1.15M	293K	1.25M	-1.49M
Change in Other Net Operating Assets	803K	-	-	-	-
Cash from Operations	-1.28M	-6.34M	-10.07M	-7.16M	-6.02M
Capital Expenditure	-38.78K	-618K	-1.04M	-23K	-17K
Sale (Purchase) of Intangible assets	-198K	-348K	-268K	-208K	-176K
Other Investing Activities, Total	-	-	-	-	254K
Cash from Investing	-237K	-966K	-1.31M	-231K	61K
Short Term Debt Repaid, Total	-	-73.55K	-	-	-
Long-Term Debt Repaid, Total	-	-	-3K	-160K	-169K
Total Debt Repaid	-	-73.55K	-3K	-160K	-169K
Issuance of Common Stock	28.19M	-	13.07M	-	8.2M
Other Financing Activities, Total	-1.44M	-	-393K	133K	-705K
Cash from Financing	26.75M	-73.55K	12.67M	-27K	7.32M
Foreign Exchange Rate Adjustments	1.39M	-35.45K	-1.83M	258K	53K
Net Change in Cash	26.63M	-7.41M	-535K	-7.16M	1.42M
Supplemental Items
Cash Interest Paid	105K	-	5K	29K	22K
Levered Free Cash Flow	-	-3.67M	-6.89M	-3.8M	-3.91M
Unlevered Free Cash Flow	-	-3.67M	-6.88M	-3.78M	-3.9M
Change In Net Working Capital	-	-863K	-428K	-425K	649K
Net Debt Issued / Repaid	-	-73.55K	-3K	-160K	-169K

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	-	-27.82	-49.55	-48.36	-50.81
Return on Total Capital	-	-29.94	-57.54	-64.5	-77.96
Return On Equity %	-	-52.71	-97.11	-115.94	-133.15
Return on Common Equity	-	-52.71	-97.11	-115.94	-133.15
Margin Analysis
Gross Profit Margin %	-	-	-	100	100
SG&A Margin	-	-	-	848.77	260.83
EBITDA Margin %	-	-	-	-748.77	-160.83
EBITA Margin %	-	-	-	-815.2	-176.46
EBIT Margin %	-	-	-	-830.6	-181.82
Income From Continuing Operations Margin %	-	-	-	-862.19	-175.92
Net Income Margin %	-	-	-	-862.19	-175.92
Net Avail. For Common Margin %	-	-	-	-862.19	-175.92
Normalized Net Income Margin	-	-	-	-510.92	-109.3
Levered Free Cash Flow Margin	-	-	-	-375.21	-117.22
Unlevered Free Cash Flow Margin	-	-	-	-373.42	-116.81
Asset Turnover
Asset Turnover	-	-	-	0.09	0.45
Fixed Assets Turnover	-	-	-	0.6	3.01
Short Term Liquidity
Current Ratio	26.51	6.09	4.58	1.14	2.24
Quick Ratio	26.21	5.87	4.43	1.07	2.02
Operating Cash Flow to Current Liabilities	-1.88	-3.51	-4.47	-2.04	-2.95
Long Term Solvency
Total Debt/Equity	0.37	-	6.08	15.18	7.05
Total Debt / Total Capital	0.37	-	5.73	13.18	6.58
LT Debt/Equity	-	-	4.73	10.6	3.59
Long-Term Debt / Total Capital	-	-	4.46	9.2	3.35
Total Liabilities / Total Assets	3.36	13.08	19.55	52.2	29.72
EBIT / Interest Expense	-22.88	-	-2.23K	-290.14	-275.95
EBITDA / Interest Expense	-20.12	-	-2.1K	-261.55	-244.09
(EBITDA - Capex) / Interest Expense	-20.5	-	-2.31K	-262.34	-244.86
Total Debt / EBITDA	-0.03	-	-0.07	-0.07	-0.07
Net Debt / EBITDA	8.4	1.45	0.87	0.28	0.69
Total Debt / (EBITDA - Capex)	-0.03	-	-0.06	-0.07	-0.07
Net Debt / (EBITDA - Capex)	8.25	1.33	0.79	0.28	0.68
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	-	-	229.62
Gross Profit, 1 Yr. Growth %	-	-	-	-	229.62
EBITDA, 1 Yr. Growth %	-	239.83	46.79	-27.74	-29.2
EBITA, 1 Yr. Growth %	-	225.28	47.65	-24.89	-28.65
EBIT, 1 Yr. Growth %	-	217.17	46.75	-24.45	-27.85
Earnings From Cont. Operations, 1 Yr. Growth %	-	17.28	36.96	-23.43	-32.75
Net Income, 1 Yr. Growth %	-	17.28	36.96	-23.43	-32.75
Normalized Net Income, 1 Yr. Growth %	-	203.89	46.12	-25.32	-29.49
Diluted EPS Before Extra, 1 Yr. Growth %	-	-28.24	17.89	-25.97	-50.76
Net Property, Plant and Equip., 1 Yr. Growth %	-	69.32	155.73	-32.19	-37.05
Total Assets, 1 Yr. Growth %	-	-32.09	3.74	-47.97	0.66
Tangible Book Value, 1 Yr. Growth %	-	-44.13	-4.4	-84.62	117.86
Common Equity, 1 Yr. Growth %	-	-38.93	-3.97	-69.09	47.98
Cash From Operations, 1 Yr. Growth %	-	394.46	58.9	-28.88	-15.92
Capital Expenditures, 1 Yr. Growth %	-	1.49K	68.28	-97.79	-26.09
Levered Free Cash Flow, 1 Yr. Growth %	-	-	87.76	-44.8	2.98
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	87.68	-45.04	3.11
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	-	-	123.34	2.99	-28.48
EBITA, 2 Yr. CAGR %	-	-	119.14	5.31	-26.79
EBIT, 2 Yr. CAGR %	-	-	115.74	5.3	-26.17
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	26.73	2.4	-28.24
Net Income, 2 Yr. CAGR %	-	-	26.73	2.4	-28.24
Normalized Net Income, 2 Yr. CAGR %	-	-	110.72	4.46	-27.44
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-8.03	-6.58	-39.63
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	108.12	31.69	-34.67
Total Assets, 2 Yr. CAGR %	-	-	-16.07	-26.53	-27.63
Tangible Book Value, 2 Yr. CAGR %	-	-	-26.91	-61.66	-42.12
Common Equity, 2 Yr. CAGR %	-	-	-23.42	-45.51	-32.36
Cash From Operations, 2 Yr. CAGR %	-	-	180.3	6.3	-22.67
Capital Expenditures, 2 Yr. CAGR %	-	-	417.88	-80.71	-87.21
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	1.81	-24.61
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	1.56	-24.72
Compound Annual Growth Rate Over Three Years
EBITDA, 3 Yr. CAGR %	-	-	-	53.32	-9.11
EBITA, 3 Yr. CAGR %	-	-	-	53.37	-7.51
EBIT, 3 Yr. CAGR %	-	-	-	52.07	-7.17
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	7.14	-10.99
Net Income, 3 Yr. CAGR %	-	-	-	7.14	-10.99
Normalized Net Income, 3 Yr. CAGR %	-	-	-	49.12	-8.37
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-14.45	-24.54
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	43.21	2.96
Total Assets, 3 Yr. CAGR %	-	-	-	-28.43	-18.4
Tangible Book Value, 3 Yr. CAGR %	-	-	-	-56.53	-31.58
Common Equity, 3 Yr. CAGR %	-	-	-	-43.4	-23.98
Cash From Operations, 3 Yr. CAGR %	-	-	-	77.45	-1.69
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-15.98	-69.81
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	2.2
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	2.08